Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Elvidge

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
British Journal of Haematology|November 21, 2014
Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL)Adrian Bloor, Erwin De Cock, Anthony J Hatswell, et al.
Plos One|September 15, 2015
Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare CostsSarah Gooding, I-Jun Lau, Mimi Sheikh, et al.
Eclinicalmedicine|August 9, 2022
Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidenceJonathan Pearson-Stuttard, Sara Holloway, Rosie Polya, et al.
International Journal of Technology Assessment in Health Care|November 4, 2024
Implementing a sandbox approach in health technology assessment: benefits and recommendationsJamie Elvidge, Nick Crabb, Diana Delnoij, et al.
Frontiers in Pharmacology|March 30, 2026
Applicability of academic real-world data research in the case studies of the HTx project to practical health technology assessment workCarl Björvang, Johan Pontén, Anders Viberg, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 25, 2024
Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI)Jamie Elvidge, Claire Hawksworth, Tuba Saygın Avşar, et al.
Frontiers in Medicine|October 10, 2022
Outcome-based reimbursement in Central-Eastern Europe and Middle-EastIldikó Ádám, Marcelien Callenbach, Bertalan Németh, et al.
Clinical Pharmacology and Therapeutics|June 21, 2023
Prognostic Factors of COVID-19: An Umbrella Review Endorsed by the International Society for PharmacoepidemiologyGrammati Sarri, Wei Liu, Luke Zabotka, et al.
The Lancet Regional Health. Europe|February 3, 2026
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across EuropeIrene López-Sánchez, Anna Palomar-Cros, Ravinder Claire, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
British Journal of Haematology|November 21, 2014
Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL)Adrian Bloor, Erwin De Cock, Anthony J Hatswell, et al.
Plos One|September 15, 2015
Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare CostsSarah Gooding, I-Jun Lau, Mimi Sheikh, et al.
Eclinicalmedicine|August 9, 2022
Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidenceJonathan Pearson-Stuttard, Sara Holloway, Rosie Polya, et al.
International Journal of Technology Assessment in Health Care|November 4, 2024
Implementing a sandbox approach in health technology assessment: benefits and recommendationsJamie Elvidge, Nick Crabb, Diana Delnoij, et al.
Frontiers in Pharmacology|March 30, 2026
Applicability of academic real-world data research in the case studies of the HTx project to practical health technology assessment workCarl Björvang, Johan Pontén, Anders Viberg, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 25, 2024
Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI)Jamie Elvidge, Claire Hawksworth, Tuba Saygın Avşar, et al.
Frontiers in Medicine|October 10, 2022
Outcome-based reimbursement in Central-Eastern Europe and Middle-EastIldikó Ádám, Marcelien Callenbach, Bertalan Németh, et al.
Clinical Pharmacology and Therapeutics|June 21, 2023
Prognostic Factors of COVID-19: An Umbrella Review Endorsed by the International Society for PharmacoepidemiologyGrammati Sarri, Wei Liu, Luke Zabotka, et al.
The Lancet Regional Health. Europe|February 3, 2026
Comorbidities, medication use, and overall survival in eight cancers: a multinational cohort study of 1.7 million patients across EuropeIrene López-Sánchez, Anna Palomar-Cros, Ravinder Claire, et al.
Pageof 3